US ▾
SLQT
Earnings call · Jun 2026 (Q4 FY26)

SelectQuote Q4 FY26 earnings call SLQT

Aug 25, 2026 Source

Executive summary

SelectQuote Q4 FY26 — Strong Cash Flow Generation and Strategic Re-focus

SelectQuote delivered strong Q4 FY26 results, exceeding EBITDA guidance and significantly improving operating cash flow, driven by operational efficiencies and the scaling healthcare services segment. The company is strategically re-focusing on profitable cash flow generation and leverage reduction in FY27, even with anticipated top-line moderation in both Senior and Healthcare Services due to market dynamics and regulatory impacts. Management sees a clear path to compounding cash flow growth and enhanced shareholder value.

Highlights

5

  • Achieved $109 million in Adjusted EBITDA for FY26, exceeding guidance range of $90 million to $100 million.

  • Delivered over $40 million of year-over-year improvement in operating cash flow for FY26.

  • Healthcare Services segment (SelectRx) reached an inflection point, exiting FY26 at nearly $50 million annual Adjusted EBITDA run rate.

  • Senior business maintained strong profitability with 26% Adjusted EBITDA margins for FY26, marking four consecutive years in the mid-20% range.

  • Identified and implemented over $30 million of annualized run rate expense improvements across the business.

Concerns

5

  • Consolidated revenue guidance for FY27 is $1.35 billion to $1.45 billion, 14% below FY26 levels at the midpoint.

  • Expected decline of 10% to 15% year-over-year in MA approved policies for FY27 due to prudent investment strategy.

  • Healthcare Services revenue expected to be down 10% to 15% in FY27, primarily due to the Inflation Reduction Act.

  • Medicare Advantage market remains fluid, dynamic, and volatile, with carriers still working towards operating margin targets.

  • Term life insurance market remains competitive with customer acquisition costs worth monitoring.

Guidance & targets

CategoryTargetConfidence
Consolidated Revenue
$1.35 billion to $1.45 billion
high materiality
High
MA Approved Policies Growth
declining 10% to 15% year over year
medium materiality
High
Healthcare Services Revenue Growth
down 10% to 15%
medium materiality
High
Consolidated Adjusted EBITDA
$90 million to $115 million
high materiality
High
Senior Segment Adjusted EBITDA Margin
above our 20% target
medium materiality
High
Healthcare Services Adjusted EBITDA Margin
approximately double
high materiality
High
Operating Cash Flow
$60 million plus
high materiality
High
Free Cash Flow
around $50 million
high materiality
High
Healthcare Services Membership
around 2026 levels
medium materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Senior
Revenue declined due to a dynamic Medicare Advantage environment and a change in a key carrier partner's strategic marketing investment. Despite this, the segment maintained strong profitability with 26% Adjusted EBITDA margins for the full year, marking four consecutive years in the mid-20% range.
Adjusted EBITDA margin: 26%
$576 million-4%—26% Adjusted EBITDA margin
Healthcare Services
Total revenue increased despite the impact from the Inflation Reduction Act. Membership moderated in Q4 to 109,000, with a focus on members providing the best unit economics. The business is scaling into a more profitable operating model, driven by the Kansas distribution facility and prescription management systems, exiting FY26 at nearly a $50 million annual EBITDA run rate.
Membership: 109,000Adjusted EBITDA: $25 millionAnnual EBITDA run rate (exit Q4 FY26): nearly $50 million
$845 million14%—$25 million Adjusted EBITDA
Life
The business delivered strong revenue and Adjusted EBITDA, which is highly cash efficient. The final expense business continues to perform well, but the term life insurance market remains competitive, leading to a focus on disciplined execution and profitable growth.
Adjusted EBITDA: $27 million
$186 million8%—$27 million Adjusted EBITDA

Risks & headwinds

Medicare Advantage Market Volatility FY27

MA approved policies declining 10% to 15% year over year in FY27

Mitigation:Prudent growth investments; focus on cash flow and profitability; nimble approach to react to market opportunities.

Inflation Reduction Act (IRA) Impact on Healthcare Services Revenue FY27

Healthcare Services revenue down 10% to 15% in FY27

Mitigation:Focus on operational efficiencies, new technology, and margin accretion to offset revenue pressure; the IRA does not materially reduce EBITDA.

Term Life Insurance Market Competitiveness Ongoing

Customer acquisition costs are worth monitoring

Mitigation:Focus on disciplined execution and profitable growth rather than assuming strong trends will continue uninterrupted.

Valuation Disconnect Ongoing

Wide disconnect in the value of our shares relative to the real cash flow generation

Mitigation:Driving expanding cash flow creation, lower leverage, and reduced funding costs to demonstrate value to equity investors.

Elevated Carrier MLRs Ongoing

MLRs still elevated relative to historical norms

Mitigation:Expectation of continued carrier discipline and some market disruption (plan terminations, benefit pullbacks) as carriers work towards operating margin targets.

What to watch in Q1 FY27

Operating Cash Flow

FY27
Current $44 million year-over-year improvement in FY26
Target approximately double to $60 million plus in FY27

Why it matters

This is the company's primary strategic priority and a key driver of shareholder value and deleveraging.

Despite the top-line pullback we discussed, we expect SelectQuote to approximately double operating cash flow in fiscal 2027 to $60 million plus.

Q&A highlights

Are there opportunities to grow healthcare services membership independently of the senior business, especially given softer MA dynamics?

While the primary focus remains on cross-sell and operational efficiencies, the company is exploring testing and learning on third-party opportunities as margins increase, allowing for customer acquisition cost (CAC) investment outside of Medicare cross-sell.

“as we increase that margin, it allows us, again, to really lean into that and find those sources and test and vet.”

asked by Benjamin Hendrix · answered by Robert Grant

2 min read 6 chapters

Detailed narrative

Strategic Focus on Profitable Cash Flow

SelectQuote's highest priority is driving profitable cash flow, with FY26 demonstrating meaningful progress. The company is managing the business with a focus on cash generation and leverage reduction to create long-term shareholder value. Management believes the platform can generate substantially more cash flow over time, and FY27 is seen as an inflection point for compounding cash flow growth and equity value.

Healthcare Services Inflection and Growth

The healthcare services division became SelectQuote's largest revenue contributor in FY26, producing approximately $25 million of adjusted EBITDA for the year and exiting at nearly a $50 million annual run rate in Q4. The company anticipates increasing cash flow and earnings power from this business in FY27, driven by operating leverage and efficiency gains from the Olathe, Kansas facility and new pharmacy management system.

Senior Business Durability and Market Adaptation

Despite a challenging Medicare Advantage environment, the senior business remained highly profitable, generating 26% adjusted EBITDA margins for FY26. This marks four consecutive years of mid-20% margins, demonstrating the durability of the model. In FY27, the company will be prudent with MA growth investments, expecting a 10-15% decline in approved policies, but remains ready to return to responsible growth when market conditions support it.

Operating Efficiency and Technology Investments

SelectQuote identified over $30 million of annualized run rate expense improvements for FY27, driven by AI and technology-enabled efficiencies, process improvements, and organizational rightsizing. Specific initiatives include AI-enabled enrollment support tools, sales assist technology, AI-powered quality assurance, and a new custom-built pharmacy management system in Olathe, Kansas, which is already recognizing 30% efficiency gains on shipments.

Fiscal 2027 Outlook and Financial Targets

For FY27, SelectQuote guides to consolidated revenue of $1.35 billion to $1.45 billion (14% below FY26 midpoint) and adjusted EBITDA of $90 million to $115 million. Despite top-line moderation, the company expects to approximately double operating cash flow to over $60 million and generate around $50 million in free cash flow. This reflects a strategic choice to prioritize profit and cash flow over top-line growth in a dynamic market.

Balance Sheet Optimization and Shareholder Value

The company aims to optimize its balance sheet and reduce funding costs, noting that every 100-basis-point decrease in its approximately 12% funding cost (on $800 million debt and preferred equity) would equate to nearly $8 million in savings for equity holders. SelectQuote expects to reduce aggregate leverage through debt repayment and expanding EBITDA, with a clear roadmap to grow equity and generate attractive returns for shareholders.

AI-generated summary of the company's earnings call. Not investment advice.